Simplify Ancorato Target 25 Distribution ETF
XXV
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- iPath Inverse S&P 500 VIX Short-Term Futures ETN (XXV) is an exchange-traded note issued by Barclays Bank PLC that seeks to replicate, net of expenses, the inverse (-100%) performance of the S&P 500 VIX Short-Term Futures Index Excess Return; the index provides exposure to a daily rolling short position in the first- and second-month VIX futures contracts, reflecting implied volatility of the S&P 500 across the short end of the volatility forward curve. Launched on July 16, 2010, by Barclays iPath with a principal amount per ETN of $20 under Global Medium-Term Notes, Series A, the ETN targets institutional and retail investors seeking short volatility exposure without leverage. Barclays Bank PLC, headquartered in London, United Kingdom, serves as the issuer and counterparty, with operations spanning global financial markets including the United States where XXV trades primarily on NYSE Arca. The ETN offers unleveraged inverse daily returns tied exclusively to the specified VIX short-term futures index, distinguishing it from long volatility products like VXX or more liquid short VIX alternatives such as SVXY; it features automatic redemption if the indicative value falls to or below $10 per note, and lacks options trading due to limited liquidity. Geographically, it operates within U.S. equity and derivatives markets, with Barclays handling issuance, distribution via Barclays Capital Inc., and risk management across North America and Europe. In recent years, Barclays announced the original early redemption and delisting of XXV effective around March 29, 2018, following volatility triggers and platform streamlining, though some data feeds show residual or adjusted trading activity into 2025 under symbols like XXVFF at prices near $25-$38. Barclays exercised issuer call options on multiple iPath ETNs in June 2025, redeeming outstanding shares with a valuation date of June 17, 2025, and redemption date of June 25, 2025, amid tender offers and indenture amendments that eliminated holder redemption rights post-call. No new product launches, acquisitions, or strategic expansions specific to XXV have occurred since 2018, with Barclays focusing on other iPath series like Series B VIX products and commodity ETNs.